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Abstract Аннотация
High prevalence of polymorbidity in 
outpatient therapeutic practice calls for 
improvement of diagnostic approaches, 
in particular, the development of methods 
for its measurement and using the results 
for optimization the number of medical, 
rehabilitation, expert and prevention processes.
The analysis of previously proposed 
methods of evaluation polymorbidity allowed 
to reveal the factors that hinder their using in 
domestic therapeutic outpatient practice.
Original methodology of integrated 
evaluation of polymorbidity adapted to the 
operating conditions of the district general 
practitioner and implemented its clinical testing.
The methodology of integrated evaluation 
of polymorbidity based on the principles of 
polyparametric analysis allows to stratify 
degree polymorbidity and significantly optimize 
the program of clinical supervision, treatment 
(including - assessing pharmacological load), 
prevention, rehabilitation, sanatorium selection, 
predicting the course and outcome of diseases, 
perform express-analysis of the degree of 
disability, cardiovascular risk in complex 
diagnostic and treatment interventions.
Keywords: polymorbidity, the
methodology of integrated evaluation of 
polymorbidity, stratification, polymorbidity 
index, primary health care.
Высокая распространенность полимор- 
бидности (П) в амбулаторной терапевтиче­
ской практике требует совершенствования 
диагностических подходов, в частности -  
разработки методик ее измерения и исполь­
зования результатов для оптимизации ряда 
лечебных, реабилитационных, экспертных 
и профилактических процессов.
Проведенный анализ ранее предложен­
ных методик оценки П позволил раскрыть 
факторы, затрудняющие их применение в 
отечественной терапевтической амбула­
торной практике.
Разработана оригинальная методика 
комплексной оценки П (МКОП), адаптиро­
ванная к условиям работы участкового вра- 
ча-терапевта и осуществлена ее клиниче­
ская апробация.
МКОП, основанная на принципах поли- 
параметрического анализа, позволяет стра­
тифицировать степень П и существенно 
оптимизировать программы диспансерного 
наблюдения, лечения (в т.ч. -  оценки фар­
макологической нагрузки), профилактики, 
реабилитации, санаторно-курортного от­
бора, прогнозирования течения и исхода 
заболеваний, выполнять экспресс-анализ 
степени утраты трудоспособности, сердеч­
но-сосудистого риска (ССР) при сложных 
лечебно-диагностических вмешательствах,
Ключевые слова: полиморбидность, 
методика комплексной оценки, стратифи­
кация, индекс полиморбидности, первич­
ная медико-санитарная помощь.
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Introduction. Polymorbidity (P) is a 
common phenomenon of outpatient practice. 
Most of the patients seeking primary health 
care (PHC) have multiple concomitant 
diseases [1, 2, 3]. At present in the conditions 
of development of evidence based medicine 
(EBM) measurement of P acquires increasing 
urgency. There are a number methods of 
its quantitative evaluation (CIRS, CIRS-G, 
indexes Kaplan-Feinstein, Charlson, ICED, 
GIC, FCI, TIBI, CDS, ACG, DUSOI) [4, 5, 6, 7, 
8, 9, 10, 11], which were developed by foreign 
researchers. Meanwhile, a comparative 
analysis of the most common valuation 
methodologies P, revealed their common 
features such as narrow specialization, 
omni directional objectives and results, 
a limited number of indicators, often, low 
sensitivity [1, 4, 5]. They also do not contain 
recommendations for P stratification in the 
practice of doctor.
In this regard, at the moment, despite 
the existing methods, the practitioner meets 
with difficulties in conducting the complex 
evaluation of P, in particular, because of the 
lack of a unified, accepted, adapted for the 
practical application methodology [12].
The high prevalence of P in the practice 
outpatient care requires further improvement 
of working with patients of this group, in 
particular -  development of а methodology 
to measure it, with subsequent using the 
results of developing in treatment programs, 
prevention, rehabilitation, working capacity 
expertise, sanatorium selection, forecasting 
risk assessments for surgical interventions and 
sophisticated diagnostic manipulations, etc.
The purpose of the study. Development 
of the methodology of integrated evaluation 
of P (MIEP) adapted for use in outpatient 
therapeutic practice and its clinical testing.
Materials and Methods. The basis of 
the MIEP are polyparametric analysis and 
EBM. Its implementation was simultaneous 
registration indicators, which were medical 
history, clinical, laboratory, instrumental, 
functional, psychological and social
parameters of health. Individual elements 
of MIEP were constructed with using the 
above described foreign methods. Particular 
attention was paid to the account of risk 
factors of cardiovascular diseases (CVD 
RF), the number of nosologic units and the 
degree of functional violations of the organs 
and systems. Later the obtained data were 
entered to the database and expressed in 
points assigned depending on the quantity or 
qualitative indicator value in this patient. The 
final result of the study was calculated using 
mathematical methods, considered as an 
index of P (PI) and was expressed in arbitrary 
units. The histograms were constructed 
for representing a complex visual image of 
health and facilitating the analysis of P. This 
gives an opportunity for physician to assess 
a number and severity of chronic diseases 
and its contribution into polymorbidity status 
of the patient, as well as, the practical use of 
PI in algorithms of short-term and long-term 
outpatient work.
Clinical testing was conducted in Policlinic 
7 of City Hospital 2 in Belgorod and have 
been intended for clinical evaluate of MIEP.
The work meets ethical principles and 
requirements defined current legislation RF, 
ICH-GCP Guidelines for conducting clinical 
trials from 01.05.1996 and the Declaration 
of Helsinki of the World Medical Association 
(version October 2000, as amended). All 
patients gave written consent to participate in 
the study, moreover, an opinion to the ethics 
committee was obtained.
In developing the methodology, data 
collection and processing materials used 
information technology applications the 
Microsoft Corporation Windows 7 OS.
Results and discussion. For the purpose 
of practical use and satisfy commonly 
accepted terminology in the methodology 
were integrated classification, medical 
and economic standards and current 
recommendations for diagnosis and 
treatment of cardiovascular diseases (CVD). 
Patient health indicators are divided into
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clusters. The first cluster included non- 
modifiable indicators, the second - modifiable 
indicators, the third - the most common 
cardiovascular syndromes and nosological 
forms, the fourth - other diseases and the 
fifth - functional status. For convenience 
of practical use and interpretation results 
of the method depending on the cluster 
membership and order of numbers each 
indicator was assigned an identification code 
(IC). Evaluation of the data was carried out 
in the points assigned depending on the 
quantity or quality indicator values in the 
patient. Indicator values ranged from 0 to 6 
points, and its increase in direct proportion to 
the pathological impact of individual indicator 
on health status and the patient's prognosis. 
The final result of the study was calculated 
using the formula 1 and considered as PI.
(1)
PI can take values ranging from 0 to 1.0 cu. 
A value of 0 cu corresponded to P, incompatible 
with life; 1.0 cu - the absence of P. The values 
in the range 1,0-0,80 cu corresponded the low 
level of P, 0,79-0,50 cu -  the average level of 
P and 0,49-0 cu -  high level of P.
Subsequently, basedontheobtained value 
of PI was performed еxpress-analysis of the 
degree and duration of incapacity for work, 
the assessment of cardiovascular risk (CVR) 
in planned operational and sophisticated 
diagnostic interventions, the sanatorium 
selection, prediction of the disease course 
and outcome. Comparative analysis MIEP 
to previously proposed methods revealed a 
number of its advantages (Table 1).
Most demonstratively advantages of 
MKOP can be traced to clinical examples.
Clinical Example 1. Patient A.., 53 
years old. Patient card number 23615. In 
accordance with the main known to date 
techniques, P in a given patient is tentatively 
estimated as low. Thus, the total score 
calculated by the system CIRS was 10 of 56
possible points, Kaplan-Feinstein index was 
8 points out of a possible 36. In accordance 
with the main known to date techniques, P 
in a given patient is tentatively estimated as 
low. Thus, the total score calculated by the 
system CIRS was 10 of 56 possible points, 
Kaplan-Feinstein index was 8 points out 
of a possible 36. Charlson index allowed, 
In addition to evaluating P (2 points out of 
40 possible in this patient that tentatively 
corresponded to the low level of P), to predict 
mortality was 26%. These methods did not 
provide further practical interpretation of the 
results. Meanwhile, obtained using MIEP PI 
was 0.86 cu, which corresponded to the low 
level of P. Analysis of histogram revealed 
pathological conditions, which have made 
the greatest contribution to the patient's A. 
polymorbidity status., and determined the 
presence of non-modifiable risk factors and 
changes in functional status.
‘Thus, the level of of the patient A. P 
determined by methods CIRS, Kaplan- 
Feinstein, Charlson, and MIEP MIEP, 
evaluated as low. At the same time MIEP 
provided the physician more detailed 
information of the structure polymorbid 
status of the patient. The main contribution 
to this having made diseases of the nervous 
and digestive systems, diseases of the 
eyes and adnexa, musculoskeletal and 
urogenital system, there were moderate 
impairments in functional status due to 
dysfunction of the joints, there were no 
cardiovascular disease. Revealed violations 
in the cluster of modifiable health indicators 
were subsequently incorporated into the 
construction of treatment and prevention 
programs. There is reason to consider that the 
therapeutic and prophylactic medicamental 
and nonmedicamental measures holding in 
relation modifiable risk factors is definitely 
will reduce the level of polymorbidity, CVD 
RF, mortality and will improve prognosis of 
the patient.
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Table 1
The comparative characteristic o f most widespread methods o f evaluation 
polymorbidity and the methodology o f integrated evaluation
o f polymorbidity
Accounted parametres CIRS CIRS-G Kaplan-Feinstein
Charl­
son
ICED MIEP
Age - + - + - +
Gender - - - - - +
CVD RF — - - - - +
Malignant neoplasms - + + - + +
Severity of nosological forms + + + - + +
Functional status - — - - + +
Prognosis - - - + + +
Stratification of degree 
patients P and efficiency of the 
measures in the dynamics
- - - - - +
Adapting to the needs 
of PHC in the Russian 
Federation (planning of clinical 
supervision, examination of 
disability, risk assessment 
for complex diagnostic and 
treatment interventions, the 
sanatorium selection, etc.)
- - - - - +
Total number of indicators 14 15 12 21 30 55
Legend:"+" -  the account parameter is provided;" -"  -  not provided.
Clinical Example 2. Patient M., 61 years 
old. Patient card number 3381. In this case 
the use of previously proposed methods give 
controversialy result. Using the system CIRS 
P of this patient evaluated in 15 of the possible 
56 points, Charlson index is 4 of 40 possible 
points, which tentatively corresponds to the low 
level of P. At the same time, Kaplan-Feinstein 
index was 13 of a possible 36 points, which 
tentatively corresponds to the average level of 
P. Mortality, according to an index Charlson, was 
52%. PI calculated using MIEP was 0.73 cu, 
which corresponded to the average level of P. 
Histogram analysis showed that the patient's M. 
polymorbid status caused by mainly diseases of 
the peripheral vascula, nervous, musculoskeletal 
and endocrine systems, essential hypertension 
and also by age. Mainly due to chronic heart 
failure, disorders statodynamic function and 
functional capacity of the patient had significant 
violations of the functional status. Thus, this
clinical examples show differences in the degree 
of P defined by methods CIRS, Kaplan-Feinstein, 
Charlson. Understatement of the patient P. M. 
defined using the system CIRS, compared with 
MIEP, due to lack of registration age in the first 
method, and using the index Charlson - limited 
set of nosology.
Clinical Example 3. Patient B., 74 years 
old. Patient card number 1754. According to 
the system CIRS P in this patient was 25 out of 
56 possible points, while the index of Kaplan- 
Feinstein - 18 out of a possible 36 points, which 
tentatively corresponds to the average level. 
Charlson index was 11 of 40 possible points, 
which tentatively corresponds to the low level of 
P. At the same time PI equaled to 0.40 cu, which 
corresponded to a high level of P. Histogram 
analysis allowed to determine the structure 
polymorbid status of the patient. This clinical 
case most clearly demonstrates the diversity 
of evaluation P using several different methods
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and possible underestimation of its degree, 
compared with MIEP, using methods CIRS, 
Kaplan-Feinstein and, in particular, -  Charleson.
An example of the practical application of 
MIEP in PHC can be a assessment of CVR for 
planned surgery and sophisticated diagnostic 
manipulations. According MIEP the assessment of 
CVR carried out depending on SP. Were identified 
as follows ranges for the stratification degree of 
CVR: 0-0,80 cu -  the risk of low-degree, 0,79­
0,50 cu -  average degree, 0,49-0,30 cu -  high 
degree and < 0,29 cu -  extremely high degree. 
Accordingly, the patient’s A. CVR was assessed 
as low, the patient M. - medium and patient
B. -  high. To predict the frequency of cardiac 
complications at surgery is currently the most 
widely used LeeIndex. Its value in the patient A. 
was 0 points (projected frequency of development 
of cardiac complications 0.4%) patient V. -  1 point 
(0.9%) and the patient B. -  2 points (7%). Clinical 
examples demonstrate conformity assessment 
results of CVR using MIEP and LeeIndex.
Thus, MIEP allows the stratification of degree 
P and use its results in the optimization of many 
both short-and long-term, clinical processes 
undertaken primarily in outpatient settings.
Conclusion. was developed jn the basis of 
the polyparametric analysis -and EBM, order 
to quantitatively evaluate P and optimization of 
various diagnostic and treatment processes, 
especially in terms PHC. The practical value of 
the method is the possibility of using its results for 
both short and long-term observation of patients: 
clinical examination, constructing treatment 
programs, prevention, rehabilitation, followed by an 
assessment of their efficiency over time, the rapid 
analysis of the degree of loss of disability evaluation 
CVR during planned surgery and sophisticated 
diagnostic manipulations, sanatorium selection. 
MIEP advantages is keeping the patient's age, 
sex, presence of malignant neoplasms, functional 
status. Development MIEP, made with regard 
to the principles of DM allowed, to a significant 
extent, to avoid a number of inconsistencies 
inherent in previously proposed methods. It is 
particularly characterized by unification, a wide 
range of tasks, higher sensitivity and the possibility 
of stratification degree of P. MKOP recommended 
for practical use in a wide network of outpatient 
medical organizations.
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